P.O. San Filippo Neri - Asl Roma 1 - Cardiologia Clinica E Riabilitativa
Welcome,         Profile    Billing    Logout  
 4 Trials 
3 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Barbato, Emanuele
NCT05437900: INSIGHTFUL-FFR Clinical Trial

Recruiting
4
2500
Europe, RoW
Pressure Microcatheter guided strategy - PIOS MC, Pressure Wire guided strategy - PIOS - PW, Pressure Microcatheter guided strategy - Standard of care, Pressure Wire guided strategy - Standard of care
CoreAalst BV, Insight Lifetech Co., Ltd.
Coronary Artery Disease, Acute Coronary Syndrome
06/26
06/30
MICROREV, NCT06356727: Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling

Recruiting
N/A
190
Europe
Thermodilution based assessment of coronary microcirculation
Azienda Ospedaliera Universitaria Integrata Verona, Abbott Medical Devices
Heart Failure, Left Ventricular Dysfunction, Idiopathic Dilated Cardiomyopathy
01/26
01/30
TARGET-IV_NA, NCT04562532: Firehawk Rapamycin Target Eluting Coronary Stent North American Trial

Active, not recruiting
N/A
1720
Europe, Canada, US
Microport Firehawk stent, MicroPort Firehawk rapamycin target eluting stent, 2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)
Shanghai MicroPort Medical (Group) Co., Ltd.
Coronary Artery Disease
12/23
06/27
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Barbato, Emanuele
NCT05437900: INSIGHTFUL-FFR Clinical Trial

Recruiting
4
2500
Europe, RoW
Pressure Microcatheter guided strategy - PIOS MC, Pressure Wire guided strategy - PIOS - PW, Pressure Microcatheter guided strategy - Standard of care, Pressure Wire guided strategy - Standard of care
CoreAalst BV, Insight Lifetech Co., Ltd.
Coronary Artery Disease, Acute Coronary Syndrome
06/26
06/30
MICROREV, NCT06356727: Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling

Recruiting
N/A
190
Europe
Thermodilution based assessment of coronary microcirculation
Azienda Ospedaliera Universitaria Integrata Verona, Abbott Medical Devices
Heart Failure, Left Ventricular Dysfunction, Idiopathic Dilated Cardiomyopathy
01/26
01/30
TARGET-IV_NA, NCT04562532: Firehawk Rapamycin Target Eluting Coronary Stent North American Trial

Active, not recruiting
N/A
1720
Europe, Canada, US
Microport Firehawk stent, MicroPort Firehawk rapamycin target eluting stent, 2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)
Shanghai MicroPort Medical (Group) Co., Ltd.
Coronary Artery Disease
12/23
06/27

Download Options